{"entity":{"type":"insider","cik":"0001841628","url":"/insider/0001841628","json_url":"/insider/0001841628.json","name":"Katz Barrett","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":4,"n_filings":2,"first":"2023-01-11","last":"2023-01-18","span_basis":"filed_date"},"name_variants":[{"name":"Katz Barrett","source":"filing","n_filings":2,"first_seen":"2023-01-11","last_seen":"2023-01-18"}],"transactions":[{"id":8568849,"accession":"0000899243-23-002075","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-002075","line_url":"/filing/0000899243-23-002075#line-4","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001841628","owner_name":"Katz Barrett","owner_display_name":"Katz Barrett","owner_url":"/insider/0001841628","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":24853.0,"shares_display":"24,853","price_per_share":37.21,"price_display":"37.21","price_state":"stated","total_value":924780.13,"total_display":"924,780.13","total_whole":"924,780","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-17","filed_date":"2023-01-18","scope":"insider"},{"id":8568841,"accession":"0000899243-23-002075","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-002075","line_url":"/filing/0000899243-23-002075#line-2","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001841628","owner_name":"Katz Barrett","owner_display_name":"Katz Barrett","owner_url":"/insider/0001841628","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4147.0,"shares_display":"4,147","price_per_share":37.01,"price_display":"37.01","price_state":"stated","total_value":153480.47,"total_display":"153,480.47","total_whole":"153,480","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-13","filed_date":"2023-01-18","scope":"insider"},{"id":7833859,"accession":"0000899243-23-001626","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0000899243-23-001626","line_url":"/filing/0000899243-23-001626#line-4","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001841628","owner_name":"Katz Barrett","owner_display_name":"Katz Barrett","owner_url":"/insider/0001841628","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":47377.0,"shares_display":"47,377","price_per_share":35.3,"price_display":"35.30","price_state":"stated","total_value":1672408.1,"total_display":"1,672,408.10","total_whole":"1,672,408","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-10","filed_date":"2023-01-11","scope":"insider"},{"id":7833853,"accession":"0000899243-23-001626","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000899243-23-001626","line_url":"/filing/0000899243-23-001626#line-2","is_derivative":false,"issuer_cik":"0001590750","issuer_name":"Viridian Therapeutics, Inc.\\DE","issuer_ticker":"VRDN","issuer_name_source":null,"issuer_url":"/issuer/0001590750","owner_cik":"0001841628","owner_name":"Katz Barrett","owner_display_name":"Katz Barrett","owner_url":"/insider/0001841628","role":"Officer (Chief Medical Officer)","role_mark":"O","role_mark_label":"Officer (Chief Medical Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Medical Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12623.0,"shares_display":"12,623","price_per_share":33.04,"price_display":"33.04","price_state":"stated","total_value":417063.92,"total_display":"417,063.92","total_whole":"417,064","shares_owned_after":0.0,"shares_owned_after_display":"0","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-01-09","filed_date":"2023-01-11","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":4,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":4,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":4},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001590750","name":"Viridian Therapeutics, Inc.\\DE","url":"/issuer/0001590750","role":"Officer (Chief Medical Officer)","n_filings":2,"first_seen":"2023-01-11","last_seen":"2023-01-18"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001841628","retrieved_at":"2026-08-26T07:11:04+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-25","last_ingest":"2026-08-26T05:24:25.741053+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}